Concord Medical Services Holdings (CCM) Cash & Equivalents (2009 - 2025)

Concord Medical Services Holdings has reported Cash & Equivalents for 17 years, with the latest figure at $42.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 39.48% year-over-year to $42.0 million; the trailing twelve-month figure through Dec 2025 stood at $42.0 million (up 39.48% YoY), and the FY2025 full-year result was $42.6 million, up 43.75% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $42.0 million, down from $24.8 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $38.2 billion in Q2 2021, with the low at $8.1 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $9.0 billion across 5 years, with a median of $38.4 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 47678.54% — and 2023, when it sank 99.69%.
• Concord Medical Services Holdings' Cash & Equivalents stood at $24.9 million in 2021, then slipped by 9.86% to $22.4 million in 2022, then slumped by 63.96% to $8.1 million in 2023, then surged by 272.79% to $30.1 million in 2024, then soared by 39.48% to $42.0 million in 2025.
• The last three Cash & Equivalents figures came in at $42.0 million (Q4 2025), $24.8 billion (Q2 2025), and $30.1 million (Q4 2024), per Business Quant data.